You have 9 free searches left this month | for more free features.

Pleural Mesothelioma

Showing 1 - 25 of 1,061

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

Not yet recruiting
  • Pleural Mesothelioma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 3, 2023

Malignant Pleural Mesothelioma Trial (Proton beam therapy)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Proton beam therapy
  • (no location specified)
Dec 14, 2022

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

TTFields in General Routine Clinical Care in Pleural

Not yet recruiting
  • Pleural Mesothelioma
  • TTFields
  • (no location specified)
Sep 9, 2022

Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

Recruiting
  • Mesotheliomas Pleural
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)

Recruiting
  • Malignant Pleural Mesothelioma
  • E-Nose testing
  • Research blood
  • Basking Ridge, New Jersey
  • +6 more
Sep 8, 2023

Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)

Recruiting
  • Malignant Pleural Mesothelioma
  • Chemotherapy Effect
  • hyperthermic intrathoracic chemotherapy
  • Cairo, Egypt
    Ain Shams University hospitals
Aug 18, 2022

Clinical, Radiological and Patient Reported Outcomes After

Recruiting
  • Pleural Diseases
  • +9 more
  • Pleural interventions
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Foundation Trust
Jun 8, 2023

Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 16, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Mesothelioma Trial in Boston (MPT Test, CLDN15/VIM Test)

Recruiting
  • Mesothelioma
  • MPT Test
  • CLDN15/VIM Test
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 21, 2022

Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

Not yet recruiting
  • Mesothelioma
  • Durvalumab / tremelimumab
  • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
  • Durham, North Carolina
  • +1 more
Jul 5, 2023

Biological Characteristics of Mesothelioma Patients

Completed
  • Malignant Mesothelioma
    • Rozzano, Milano, Italy
    • +1 more
    Sep 8, 2022

    Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

    Recruiting
    • Malignant Pleural Effusion
    • +3 more
    • Leicester, United Kingdom
    • +5 more
    Oct 28, 2022

    Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

    Active, not recruiting
    • Malignant Pleural Mesothelioma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 25, 2022

    Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

    Recruiting
    • Malignant Pleural Mesothelioma
    • Safety
    • Expansion Cohort
    • New York, New York
      Icahn School of Medicine Mount Sinai
    Mar 31, 2022

    Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma

    Recruiting
    • Mesothelioma, Malignant
      • Shinjuku-ku, Tokyo, Japan
        Local Institution
      Apr 5, 2022

      Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)

      Active, not recruiting
      • Mesothelioma
      • +2 more
      • Galinpepimut-S
      • +2 more
      • Basking Ridge, New Jersey
      • +5 more
      Nov 23, 2022

      Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)

      Recruiting
      • Pleural Mesothelioma
      • Immunotherapy
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)

      Completed
      • Pleural Mesothelioma Malignant Advanced
      • Barcelona, Spain
      • +14 more
      Aug 23, 2022